文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

循环组蛋白参与单核细胞及MDW改变,是经典脓毒症与COVID-19脓毒症的共同介质

Circulating histones contribute to monocyte and MDW alterations as common mediators in classical and COVID-19 sepsis.
PubMed 文献 · Crit Care · 2022-08-30
一句话结论体外实验显示组蛋白可使健康全血MDW出现与经典脓毒症和COVID-19脓毒症患者相似的持续升高,作者认为组蛋白可能参与两种脓毒症的单核细胞改变。

本研究比较COVID-19与脓毒症患者全血的MDW指数,并用组蛋白及组蛋白加脂多糖体外处理健康对照全血以模拟病毒性与经典脓毒症。结果显示,组蛋白体外处理健康全血可致MDW早期、持续且显著升高,变化与经典和病毒性脓毒症患者体内所见相似,机制与组蛋白诱导的单核细胞体积、胞质颗粒度与空泡化及核结构改变相关。作者认为组蛋白可能参与两种急性脓毒症中显著而持续的单核细胞改变,循环组蛋白对血细胞的影响应被视为调节血栓形成与炎症过程的关键因素,并提及肝素类等药物中和其细胞毒与促凝活性的重要性。

要点

  • 组蛋白体外处理健康全血可致MDW指数早期、持续且显著升高,与经典脓毒症和COVID-19脓毒症患者体内变化相似。
  • MDW升高机制与组蛋白诱导的单核细胞体积、胞质颗粒度与空泡化及核结构改变相关。
  • 作者认为循环组蛋白可能参与经典与病毒性脓毒症中显著而持续的单核细胞改变。
  • 作者认为组蛋白对血细胞的影响是调节血栓形成与炎症过程的关键因素,并提及肝素类与类肝素药物中和其细胞毒与促凝活性。

适用人群与场景

  • COVID-19患者与脓毒症患者全血样本,用于比较MDW指数。
  • 健康对照全血,用于体外组蛋白及组蛋白加脂多糖处理实验。

研究设计与关键结果

  • 研究设计为比较COVID-19与脓毒症患者全血MDW指数,并用组蛋白及组蛋白加脂多糖体外时间依赖性处理健康对照全血,分别模拟病毒性与经典脓毒症。
  • 组蛋白体外处理健康全血可致MDW指数早期、持续且显著升高,变化与经典和病毒性脓毒症患者体内所见相似。
  • MDW改变机制与组蛋白诱导的单核细胞体积、胞质颗粒度与空泡化及核结构改变相关。

证据类型、等级与局限

  • 证据类型:体外实验结合患者全血MDW比较。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,循环组蛋白对血细胞的影响应被视为调节血栓形成与炎症过程的关键因素。
  • 作者认为,应重视多种市售药物(如肝素类与类肝素药物)中和组蛋白细胞毒与促凝活性的作用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: Histone proteins are physiologically involved in DNA packaging and gene regulation but are extracellularly released by neutrophil/monocyte extracellular traps and mediate thrombo-inflammatory pathways, associated to the severity of many human pathologies, including bacterial/fungal sepsis and COVID-19. Prominent and promising laboratory features in classic and viral sepsis emphasize monocyte distribution width (MDW), due to its ability to distinguish and stratify patients at higher risk of critical conditions or death. No data are available on the roles of histones as MDW modifiers.

DESIGN: Comparison of MDW index was undertaken by routine hematology analyzer on whole blood samples from patients with COVID-19 and Sepsis. The impact of histones on the MDW characteristics was assessed by the in vitro time-dependent treatment of healthy control whole blood with histones and histones plus lipopolysaccharide to simulate viral and classical sepsis, respectively.

MEASUREMENTS AND MAIN RESULTS: We demonstrated the breadth of early, persistent, and significant increase of MDW index in whole blood from healthy subject treated in vitro with histones, highlighting changes similar to those found in vivo in classic and viral sepsis patients. These findings are mechanistically associated with the histone-induced modifications of cell volume, cytoplasmic granularity and vacuolization, and nuclear structure alterations of the circulating monocyte population.

CONCLUSIONS: Histones may contribute to the pronounced and persistent monocyte alterations observed in both acute classical and viral sepsis. Assessment of the biological impact of circulating histone released during COVID-19 and sepsis on these blood cells should be considered as key factor modulating both thrombosis and inflammatory processes, as well as the importance of neutralization of their cytotoxic and procoagulant activities by several commercially available drugs (e.g., heparins and heparinoids).

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Ligi D, Lo Sasso B, Giglio RV, et al. Circulating histones contribute to monocyte and MDW alterations as common mediators in classical and COVID-19 sepsis. Crit Care. 2022. PMID: 36042461. doi:10.1186/s13054-022-04138-2

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。